<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39386928</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Patient Characteristics and Clinical Outcomes During the 2020-2021 COVID-19 Wave: An Observational Study at a Tertiary Hospital in Saudi Arabia.</ArticleTitle><Pagination><StartPage>e71119</StartPage><MedlinePgn>e71119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e71119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.71119</ELocationID><Abstract><AbstractText>Background and objective The continued prevalence and threat of coronavirus disease 2019 (COVID-19) have been reported, and evidence suggests that several people still get infected with the virus. Gaining a thorough understanding of the patient demographic factors and laboratory findings could contribute to assessing the severity, mortality, and progression of COVID-19. In light of this, the current study aimed to evaluate the demographic characteristics, laboratory findings, and outcomes of confirmed COVID-19 patients at a tertiary hospital in the Kingdom of Saudi Arabia (KSA). Methodology We collected data spanning the period 2020-2021 from the electronic health records of Al-Noor Specialized Hospital, Ma including demographics (age, gender, and nationality), severity (i.e., ICU admission), length of hospital stay, mortality, and laboratory parameters. Results We observed an overall mortality rate of 10.2% (338 of 3,307 patients). The mortality rate was significantly higher in males (n=210; 62.1%) and patients aged more than 70 years (n=91; 26.9%). Patients with blood group O comprised 131 (29%) of the 338 non-survivors, followed by those with A (n=85; 25.1%) and B groups (n=79; 23.4%). The mortality rate among ICU patients was 63.3% (n=214). Furthermore, the following laboratory findings showed abnormal mean values in terms of severity and mortality in COVID-19 patients: hemoglobin (HB) concentration, white blood cell (WBC) count, lymphocyte count (LC), C-reactive protein (CRP), creatinine (CREA), and uric acid (UA) levels. Conclusions Old age, male gender, and certain laboratory findings have a critical role in the severity and mortality risk in COVID-19 patients. There was no significant association between blood type and the severity and mortality of COVID-19. Continuous monitoring based on these findings may be essential to managing COVID-19 patients.</AbstractText><CopyrightInformation>Copyright © 2024, Ahmed et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Omar B</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Environmental and Health Research, Umm Al-Qura University, Makkah, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghar</LastName><ForeName>Atif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Environmental and Health Research, Umm Al-Qura University, Makkah, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamaga</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Environmental and Health Research, Umm Al-Qura University, Makkah, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abd El-Rahim</LastName><ForeName>Ibrahim H</ForeName><Initials>IH</Initials><AffiliationInfo><Affiliation>Environmental and Health Research, Umm Al-Qura University, Makkah, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mashat</LastName><ForeName>Bassam</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Environmental and Health Research, Umm Al-Qura University, Makkah, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khogeer</LastName><ForeName>Asim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institutional Review Board, General Directorate of Health Affairs Makkah Region, Ministry of Health, Makkah, SAU.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Office, General Directorate of Health Affairs Makkah Region, Ministry of Health, Makkah, SAU.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assaggaf</LastName><ForeName>Hamza</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory Medicine/Public Health, Umm Al-Qura University, Makkah, SAU.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">demographics</Keyword><Keyword MajorTopicYN="N">laboratory findings</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">severity</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Institutional Review Board of the Directorate of Health Affairs (DHA) in the Makkah Region issued approval H-02-K-076-0920-372, Dated 04.10.2020. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>5</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39386928</ArticleId><ArticleId IdType="pmc">PMC11462384</ArticleId><ArticleId IdType="doi">10.7759/cureus.71119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The increase in SARS-CoV-2 lineages during 2020-2022 in a state in the Brazilian Northeast is associated with a number of cases. Freitas MT, Sena LO, Fukutani KF, et al. Front Public Health. 2023;11:1222152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10771345</ArticleId><ArticleId IdType="pubmed">38186707</ArticleId></ArticleIdList></Reference><Reference><Citation>Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage. Scheepers C, Everatt J, Amoako DG, et al. Nat Commun. 2022;13:1976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8993834</ArticleId><ArticleId IdType="pubmed">35396511</ArticleId></ArticleIdList></Reference><Reference><Citation>Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants. Stadtmüller M, Laubner A, Rost F, et al. Virus Evol. 2022;8:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9048873</ArticleId><ArticleId IdType="pubmed">35494175</ArticleId></ArticleIdList></Reference><Reference><Citation>Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Sigal A, Milo R, Jassat W. Nat Rev Immunol. 2022;22:267–269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002222</ArticleId><ArticleId IdType="pubmed">35414124</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia. Abolfotouh MA, Musattat A, Alanazi M, Alghnam S, Bosaeed M. BMC Infect Dis. 2022;22:950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9758036</ArticleId><ArticleId IdType="pubmed">36526994</ArticleId></ArticleIdList></Reference><Reference><Citation>ABO blood group and outcomes in patients with COVID-19 admitted in the intensive care unit (ICU): a retrospective study in a tertiary-level hospital in Bangladesh. Halim MR, Saha S, Haque IU, et al. J Multidiscip Healthc. 2021;14:2429–2436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8421326</ArticleId><ArticleId IdType="pubmed">34511926</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood type and outcomes in patients with COVID-19. Latz CA, DeCarlo C, Boitano L, et al. Ann Hematol. 2020;99:2113–2118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7354354</ArticleId><ArticleId IdType="pubmed">32656591</ArticleId></ArticleIdList></Reference><Reference><Citation>The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Lippi G, Plebani M. Clin Chem Lab Med. 2020;58:1063–1069.</Citation><ArticleIdList><ArticleId IdType="pubmed">32191623</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Cavezzi A, Troiani E, Corrao S. Clin Pract. 2020;10:1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Plasma CRP level is positively associated with the severity of COVID-19. Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Ann Clin Microbiol Antimicrob. 2020;19:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227180</ArticleId><ArticleId IdType="pubmed">32414383</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and laboratory features of COVID-19: predictors of severe prognosis. Bastug A, Bodur H, Erdogan S, et al. Int Immunopharmacol. 2020;88:106950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480980</ArticleId><ArticleId IdType="pubmed">32919217</ArticleId></ArticleIdList></Reference><Reference><Citation>Health issues in the Hajj pilgrimage: a literature review. Aldossari M, Aljoudi A, Celentano D. East Mediterr Health J. 2019;25:744–753.</Citation><ArticleIdList><ArticleId IdType="pubmed">31774140</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and epidemiological characteristics of COVID-19 mortality in Saudi Arabia. Alsayer RM, Alsharif HM, Al Baadani AM, Kalam KA. Saudi Med J. 2021;42:1083–1094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129245</ArticleId><ArticleId IdType="pubmed">34611003</ArticleId></ArticleIdList></Reference><Reference><Citation>Comorbidities and risk factors for severe outcomes in COVID-19 patients in Saudi Arabia: a retrospective cohort study. Shaikh FS, Aldhafferi N, Buker A, et al. J Multidiscip Healthc. 2021;14:2169–2183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367214</ArticleId><ArticleId IdType="pubmed">34408431</ArticleId></ArticleIdList></Reference><Reference><Citation>Features of anosmia in COVID-19. Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royer PY, Lepiller Q, Gendrin V, Zayet S. Med Mal Infect. 2020;50:436–439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162775</ArticleId><ArticleId IdType="pubmed">32305563</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for death in adult COVID-19 patients: frailty predicts fatal outcome in older patients. Tehrani S, Killander A, Åstrand P, Jakobsson J, Gille-Johnson P. Int J Infect Dis. 2021;102:415–421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833745</ArticleId><ArticleId IdType="pubmed">33130213</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. J Infect Public Health. 2020;13:920–925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833063</ArticleId><ArticleId IdType="pubmed">32534945</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiological and clinical features of COVID-19 patients in Saudi Arabia. Alahmari AA, Khan AA, Elganainy A, Almohammadi EL, Hakawi AM, Assiri AM, Jokhdar HA. J Infect Public Health. 2021;14:437–443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831680</ArticleId><ArticleId IdType="pubmed">33743364</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Huang C, Wang Y, Li X, et al. Lancet. 2020;395:497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Longer length of stay, days between discharge/first readmission, and pulmonary involvement ≥50% increase prevalence of admissions in ICU in unplanned readmissions after COVID-19 hospitalizations. Peixoto SG, Wolf JM, Glaeser AB, Maccari JG, Nasi LA. J Med Virol. 2022;94:3750–3756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9347576</ArticleId><ArticleId IdType="pubmed">35506668</ArticleId></ArticleIdList></Reference><Reference><Citation>Demographic characteristics, comorbidities, and length of stay of COVID-19 patients admitted into intensive care units in Saudi Arabia: a nationwide retrospective study. Al-Otaiby M, Almutairi KM, Vinluan JM, et al. Front Med (Lausanne) 2022;9:893954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9325959</ArticleId><ArticleId IdType="pubmed">35911421</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood group A enhances SARS-CoV-2 infection. Wu SC, Arthur CM, Jan HM, et al. Blood. 2022;140:79–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10294591</ArticleId><ArticleId IdType="pubmed">37367252</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality. Ishaq U, Malik A, Malik J, et al. PLoS One. 2021;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670663</ArticleId><ArticleId IdType="pubmed">34905588</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term mortality in very old survivors of COVID-19. Serratrice C, Jean M, Herrmann F, et al. J Am Med Dir Assoc. 2024;25:105047.</Citation><ArticleIdList><ArticleId IdType="pubmed">38825322</ArticleId></ArticleIdList></Reference><Reference><Citation>Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. PLoS One. 2021;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8270145</ArticleId><ArticleId IdType="pubmed">34242273</ArticleId></ArticleIdList></Reference><Reference><Citation>Gender differences in estimated excess mortality during the COVID-19 pandemic in Thailand. Pothisiri W, Prasitsiriphon O, Apakupakul J, Ploddi K. BMC Public Health. 2023;23:1900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10544589</ArticleId><ArticleId IdType="pubmed">37784059</ArticleId></ArticleIdList></Reference><Reference><Citation>The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. Int J Gen Med. 2014;7:417–423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4149400</ArticleId><ArticleId IdType="pubmed">25187734</ArticleId></ArticleIdList></Reference><Reference><Citation>The relationship of ABO and Rh blood group types with severe COVID-19 disease mortality in ICU patients: insights from a single-center experience in southern Saudi Arabia. Al Bshabshe A, Alqahtani M, Amer KA, et al. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10800029</ArticleId><ArticleId IdType="pubmed">38249239</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiological, clinical, and laboratory findings of 235 hospitalized COVID-19 adult patients (survivors and non-survivors) at Sohar Hospital in Oman. Al Khan A, Al Balushi N, Al Maqbali S, Al Risi E, Al Maktoumi T, Al Mamari S, Al Balushi A. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10733782</ArticleId><ArticleId IdType="pubmed">38130539</ArticleId></ArticleIdList></Reference><Reference><Citation>The novel Chinese coronavirus (2019‐nCoV) infections: challenges for fighting the storm. Bassetti M, Vena A, Giacobbe DR. Eur J Clin Invest. 2020;50:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7163647</ArticleId><ArticleId IdType="pubmed">32003000</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>